Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: A brief review

Journal of Thoracic Oncology

Volumn 3, Issue 5, 2008, Pages 534-538

  Kased, Norbert ^a   Erasmus, Jeremy J ^b   Komaki, Ritsuko ^b   Cox, James D ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Box 0097   (United States)

Author keywords

Non small cell lung carcinoma (NSCLC); Positron emission tomography (PET); Prognosis; Radiation Therapy; 18F fluorodeoxyglucose (FDG)

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 43049094083     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31816de265     Document Type: Article

References (24)

1. JF Bruzzi RF Munden PET/CT imaging of lung cancer J Thorac Imaging 21 2006 123 136
2. ME Juweid BD Cheson Positron-emission tomography and assessment of cancer therapy N Engl J Med 354 2006 496 507
3. J Vansteenkiste BM Fischer C Dooms J Mortensen Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review Lancet Oncol 5 2004 531 540
4. D Lardinois W Weder TF Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507
5. BM Fischer J Mortensen SW Langer A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis Ann Oncol 18 2007 338 345
6. YE Erdi K Rosenzweig AK Erdi Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) Radiother Oncol 62 2002 51 60
7. U Nestle K Walter S Schmidt 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int J Radiat Oncol Biol Phys 44 1999 593 597
8. K Mah CB Caldwell YC Ung The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study Int J Radiat Oncol Biol Phys 52 2002 339 350
9. D De Ruysscher S Wanders A Minken Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study Radiother Oncol 77 2005 5 10
10. A van Der Wel S Nijsten M Hochstenbag Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2–N3M0 non-small-cell lung cancer: a modeling study Int J Radiat Oncol Biol Phys 61 2005 649 655
11. J Bradley WL Thorstad S Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86
12. MP Mac Manus RJ Hicks DL Ball F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment Cancer 92 2001 886 895
13. B Movsas TA Raffin AH Epstein CJ Link Jr Pulmonary radiation injury Chest 111 1997 1061 1076
14. G Pillot BA Siegel R Govindan Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review J Thorac Oncol 1 2006 152 159
15. ME Hebert VJ Lowe JM Hoffman EF Patz MS Anscher Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings Am J Clin Oncol 19 1996 416 421
16. Y Ichiya Y Kuwabara M Sasaki A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma Ann Nucl Med 10 1996 193 200
17. NC Choi AJ Fischman A Niemierko Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 54 2002 1024 1035
18. JS Ryu NC Choi AJ Fischman TJ Lynch DJ Mathisen FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology Lung Cancer 35 2002 179 187
19. MP Mac Manus RJ Hicks JP Matthews A Wirth D Rischin DL Ball Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure Lung Cancer 49 2005 95 108
20. C Pottgen S Levegrun D Theegarten Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy Clin Cancer Res 12 2006 97 106
21. A van Baardwijk G Bosmans A Dekker Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients Radiother Oncol 82 2007 145 152
22. M Werner-Wasik Y Xiao E Pequignot WJ Curran W Hauck Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study Int J Radiat Oncol Biol Phys 51 2001 56 61
23. HI Libshitz DG Sheppard Filling in of radiation therapy-induced bronchiectatic change: a reliable sign of locally recurrent lung cancer Radiology 210 1999 25 27
24. AM Lever D Henderson DA Ellis PA Corris JJ Gilmartin Radiation fibrosis mimicking local recurrence in small cell carcinoma of the bronchus Br J Radiol 57 1984 178 180